Chemotherapy Doctors Abroad — Page 6

Professor Kim Tae Joong is a senior specialist at Samsung Medical Center, focusing on medical treatments for complex female cancers.

• Specialises in gynaecologic oncology at one of Korea's most prestigious university hospitals
• Active member of the Korean Society of Gynecologic Oncology
• Experienced in managing chemotherapy protocols for ovarian and cervical malignancies
• Focuses on evidence-based cancer care through ongoing clinical research in oncogynecology

Professor Ahmet Bilici leads the medical oncology department at Medipol Mega University Hospital, where he focuses on complex chemotherapy protocols for lung cancer and sarcomas.

• Holds the rank of Professor in the Department of Medical Oncology
• Specialises in managing high-risk cases including various types of soft tissue sarcoma
• Consults at one of Turkey's largest university-affiliated medical centres
• Focuses on personalized systemic therapies tailored to specific tumour pathology

Associate Professor Murat Ayhan is a leading medical oncologist at Liv Hospital Vadistanbul, specialising in advanced drug therapies and precision medicine for complex cancers.

• International investigator for Phase III trials involving targeted therapies for metastatic breast cancer
• Published expert in managing chemotherapy side effects and drug desensitisation techniques
• Member of the European Society of Medical Oncology (ESMO)
• Author of a professional medical manual on common clinical chemotherapy regimens
• Specialised focus on immunotherapy and 'smart' drug protocols for lung and colorectal cancers

Associate Professor Mehmet Hilmi Dogu is a leading hematology specialist at Liv Hospital Ulus with deep expertise in managing complex blood cancers. He previously served as the Responsible Authority for the Istanbul Training and Research Hospital Hematology Clinic.

• Specialises in chemotherapy protocols for Hodgkin's and Non-Hodgkin's lymphoma
• Focuses on chronic leukaemia and myeloproliferative diseases like Myelofibrosis
• Board member for the Society of Hematological Education and Research
• Published 32 articles in international peer-reviewed journals on blood disorders
• Completed specialised training at the ESCCA Summer School on Cytometry in Prague

Professor Hilmi Apak led the Paediatric Haematology-Oncology Division at Istanbul University for over two decades and now brings his expertise to Biruni University Hospital.

• Specialises in chemotherapy for leukaemia and bone marrow transplantation
• Served as Head of the Department of Paediatrics at Istanbul University
• Published 75 papers in international medical journals regarding childhood blood disorders
• Provides advanced treatments including CAR T-cell therapy for complex cases
• Board member of the Turkish Paediatric Society and the Turkish Adolescent Association

Associate Professor Nail Paksoy is a highly active researcher in chemotherapy, serving as a sub-investigator for major trials with ROCHE, Pfizer, and AstraZeneca.

• Holds European Board Certification in Medical Oncology (ESMO), a gold standard in cancer care
• Specialises in managing chemotherapy-induced complications like thrombocytopenia
• Expert in carboplatin desensitisation protocols for patients with ovarian carcinoma
• Focuses on advanced treatments for lung, breast, and gastrointestinal cancers
• Published extensive real-world data on chemotherapy effectiveness for rare sarcomas

Professor Cetindag has published over 100 research works on cancer care, focusing on combining chemotherapy with precision radiotherapy at Medipol Mega University Hospital.

• Specialises in managing complex solid tumours throughout the head and neck
• Experienced in designing integrated chemotherapy and radiation protocols
• Contributed 22 articles to international medical journals on treatment outcomes
• Former specialist at the Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital
• Expertise includes chemotherapy planning for localized prostate cancer cases